Healthcare -
Biotechnology - NASDAQ - US
$ 2.6
-0.763 %
$ 75.1 M
Market Cap
-0.87
P/E
AVTE - TOTAL CURRENT ASSETS
Total Current Assets AVTE - Aerovate Therapeutics, Inc.
124 M
LAST VALUE
-15.58%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR